Trauzettel-Klosinski S, Aulhorn E, Diener H C, Minder C, Pfluger D
Abteilung für Pathophysiologie des Sehens und Neuroophthalmologie, Universitäts-Augenklinik, Tübingen, Bundesrepublik Deutschland.
Fortschr Ophthalmol. 1991;88(5):490-501.
The treatment of optic neuritis (ON) with corticosteroids has been controversial for many years. None of the previous studies with the usual dosage of steroids or ACTH has proven that this therapy is beneficial. However, these studies did not apply sensitive parameters for assessing the course of ON. The aim of this study was to examine the effect of corticosteroids using subtle parameters. The study design emphasized: 1. strict criteria for patient selection; 2. frequent controls during the initial period of the disease, follow-up for 1 year; 3. double-blind conditions with randomized groups; 4. assessment of the course with sensitive parameters, including visual acuity, visual evoked potentials (VEP) and the Tübingen Flikker Test, also called the Aulhorn Flicker Test, which monitors the activity of the ON. These last two tests were used for the first time in a controlled treatment study in ON. Thirty-eight patients with acute ON were treated orally in a double-blind procedure with either methylprednisolone (initially 100 mg daily, reduction every 3 days) or with vitamin B1 (100 mg thiamin daily) in the control group. The results of the Flicker Test and VEP showed a trend toward faster recovery under prednisolone within the first few weeks after onset of the disease. After 1 year none of the parameters examined showed any difference between the two groups. Thus, although prednisolone treatment in the dosage mentioned above seems to speed up recovery in the initial phase in some patients, no long-term benefit could be demonstrated.
多年来,使用皮质类固醇治疗视神经炎(ON)一直存在争议。以往使用常规剂量类固醇或促肾上腺皮质激素(ACTH)的研究均未证明这种治疗方法有益。然而,这些研究并未应用敏感参数来评估视神经炎的病程。本研究的目的是使用精细参数来检验皮质类固醇的效果。该研究设计强调:1. 严格的患者选择标准;2. 在疾病初期进行频繁对照,随访1年;3. 随机分组的双盲条件;4. 使用敏感参数评估病程,包括视力、视觉诱发电位(VEP)和图宾根闪烁试验(也称为奥尔霍恩闪烁试验),该试验可监测视神经炎的活动情况。最后这两项试验首次用于视神经炎的对照治疗研究。38例急性视神经炎患者采用双盲程序口服治疗,治疗组给予甲泼尼龙(初始剂量为每日100mg,每3天减量),对照组给予维生素B1(每日100mg硫胺素)。闪烁试验和VEP的结果显示,在疾病发作后的最初几周内,泼尼松龙治疗组的恢复趋势更快。1年后,两组之间在所有检测参数上均无差异。因此,尽管上述剂量的泼尼松龙治疗似乎在某些患者的初始阶段能加速恢复,但未显示出长期益处。